Imidazonaphthyridines and their use in inducing cytokine biosynthesis
Details for Australian Patent Application No. 2002300984 (hide)
International Classifications
Event Publications
20 February 2003 Application Open to Public Inspection
Published as AU-B-2002300984
12 August 2004 Amendment Made
The nature of the amendment is: Delete the co-inventor Gerster, John F. and add co-inventor Rice, Michael J.
2 December 2004 Application Accepted
Published as AU-B-2002300984
7 April 2005 Standard Patent Sealed
10 July 2008 Assignment Registered
Minnesota Mining and Manufacturing Company The patent has been assigned to Takeda Pharmaceutical Company Limited
8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002300985-Imidazonaphthyridines And Their Use In Inducing Cytokine Biosynthesis
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser